13F reference period
n/a
Security Snapshot
Keenova Therapeutics plc - Ordinary Shares, par value $0.01 per share (MNKTQ) Institutional Ownership
CUSIP: G5890A102
13F Institutional Holders and Ownership History from Q2 2022 to Q4 2023
Institutions Reporting
Shares (Excl. Options)
n/a
Price
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Ordinary Shares, par value $0.01 per share
- Symbol
- MNKTQ
- Shares outstanding
- 39,637,685
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- MNKTQ - Keenova Therapeutics plc - Ordinary Shares, par value $0.01 per share is tracked under CUSIP G5890A102.
- 13F reference-period holder data is not available.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder data for the Q2 2026 reference period is not available.
- Available periods remain in the history table; they do not substitute for the headline period.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
G5890A102
13F reference period
n/a
13F holders
13D/G owners
6
CIK / CUSIP context first
MNKTQ full holder history
Keenova Therapeutics plc SEC filings
Keenova Therapeutics plc company facts
Keenova Therapeutics plc insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP G5890A102:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
MNKTQ
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| GOLDENTREE ASSET MANAGEMENT LP | 21% | +5.5% | 8,442,827 | +6.3% | Steven A. Tananbaum | 24 Sep 2026 | ||
| Silver Point Capital L.P. | 15% | +7.1% | 6,035,214 | +7.1% | Silver Point Capital, L.P. | 20 May 2026 | ||
| MARATHON ASSET MANAGEMENT LP | 6.8% | -11% | 2,710,229 | -11% | MARATHON ASSET MANAGEMENT GP, L.L.C. | 31 Mar 2026 | ||
| Hein Park Capital Management LP | 5.5% | +12% | 2,146,733 | +9.8% | Hein Park Capital Management LP | 31 Dec 2025 | ||
| Hudson Bay Capital Management LP | 5.2% | -18% | 2,049,739 | -17% | Hudson Bay Capital Management LP | 31 Dec 2025 | ||
| Flynn James E | 4.1% | 804,259 | Deerfield Management Company, L.P. | 31 Mar 2025 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
7
Headline period
n/a
Rows shown
1-7 of 7
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2023 Q4 | 0 | $0 | -$12,483 | 0 | |
| 2023 Q3 | 146,419 | $12,483 | -$12,306,264 | $0.09 | 2 |
| 2023 Q2 | 10,483,926 | $12,366,901 | -$11,282,467 | $1.18 | 35 |
| 2023 Q1 | 10,313,801 | $75,218,046 | -$870,603 | $7.29 | 44 |
| 2022 Q4 | 10,324,766 | $80,489,118 | +$79,299,231 | $7.75 | 45 |
| 2022 Q3 | 52,297 | $889,000 | +$10,000 | $17.01 | 2 |
| 2022 Q2 | 48,731 | $1,211,000 | +$1,211,000 | $24.86 | 2 |